TY  - JOUR
AU  - Godoy-Ortiz, Ana
AU  - Sanchez-Muñoz, Alfonso
AU  - Chica-Parrado, Maria Rosario
AU  - Alvarez, Martina
AU  - Ribelles, Nuria
AU  - Rueda-Dominguez, Antonio
AU  - Alba, Emilio
PY  - 2019
DO  - 10.3389/fonc.2019.01124
SN  - 2234-943X
UR  - http://hdl.handle.net/10668/14703
T2  - Frontiers in oncology
AB  - The main obstacle for designing effective treatment approaches in breast cancer is the extensive and the characteristic heterogeneity of this tumor. The vast majority of critical genomic changes occurs during breast cancer progression, creating a...
LA  - en
PB  - Frontiers Research Foundation
KW  - HER2-enriched
KW  - HER2-positive
KW  - Breast cancer
KW  - Heterogeneity
KW  - Intrinsic subtype
KW  - Molecular
KW  - Retrospective Studies
KW  - Neoplasms
KW  - Neoplastic Processes
KW  - Genomics
KW  - Cell Proliferation
TI  - Deciphering HER2 Breast Cancer Disease: Biological and Clinical Implications.
TY  - research article
VL  - 9
ER  -